9
Total deals
$6.6B
Total value
$1.1B
Avg deal
$2.5B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Longboard Pharmaceuticals
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pha…
|
2024-10-14 | Acquisition | Complete | $2.5B | Deal → |
| 2 |
Alder Biopharmaceuticals
Alder Biopharmaceuticals uses their proprietary technologies to accelerate antib…
|
2019-09-16 | Acquisition | Complete | $1.9B | Deal → |
| 3 |
Abide Therapeutics
Abide Therapeutics is a pharmaceutical company developing serine hydrolase inhib…
|
2019-05-06 | Acquisition | Complete | $250.0M | Deal → |
| 4 |
Prexton Therapeutics
Prexton Therapeutics has the mission to develop innovative drugs to improve the …
|
2018-03-16 | Acquisition | Complete | $1.1B | Deal → |
| 5 |
Chelsea Therapeutics International
Chelsea Therapeutics International is a pharmaceutical company developing and co…
|
2014-05-08 | Acquisition | Complete | $658.0M | Deal → |
| 6 |
Laboratoire Elaiapharm
Laboratoire Elaiapharm a pharmaceutical contract manufacturing organization, pro…
|
2009-10-07 | Acquisition | Complete | — | Deal → |
| 7 |
Ovation Pharmaceuticals
Pharmaceutical Manufacturer
|
2009-02-09 | — | Complete | — | Deal → |
| 8 |
Saegis Pharmaceuticals
Saegis Pharmaceuticals is focused on the development of medicines that address b…
|
2008-11-25 | Acquisition | Complete | — | Deal → |
| 9 |
S
Synaptic Pharmaceuticals
Synaptic Pharmaceuticals develops human receptor-targeted drug design technology…
|
2002-11-21 | Acquisition | Complete | $121.0M | Deal → |